Prevention Study Introduces Alzheimer’s Retinal Imaging Eye Test

NeuroVision announced its participation in the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (or “A4”) clinical trial.  They will be working with investigators at the University of California San Diego School of Medicine (UC San Diego) and the University of Southern California (USC). The purpose of the A4 study is to test whether a new investigational treatment called "solanezumab" can slow or prevent memory loss caused by Alzheimer’s. Beta-amyloid is the main suspect behind Al...
More